Genomma Lab Internacional, S.A.B. de C.V.
GNMLF
$1.16
$0.07927.33%
OTC PK
| 06/30/2025 | 03/31/2025 | 06/30/2024 | 06/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -25.47% | 14.72% | 67.21% | 67.21% | 67.21% |
| Total Depreciation and Amortization | -0.65% | -21.31% | -34.51% | -34.51% | -34.51% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 100.15% | 541.41% | 0.57% | 0.57% | 0.57% |
| Change in Net Operating Assets | 73.75% | -216.38% | 35.95% | 35.95% | 35.95% |
| Cash from Operations | 453.32% | -111.55% | 421.00% | 421.00% | 421.00% |
| Capital Expenditure | 14.48% | 37.83% | 65.50% | 65.50% | 65.50% |
| Sale of Property, Plant, and Equipment | -- | -- | 312.47% | 312.47% | 312.47% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -158.25% | -72.56% | -445.99% | -445.99% | -445.99% |
| Cash from Investing | -53.90% | -125.06% | -201.95% | -201.95% | -201.95% |
| Total Debt Issued | 182.35% | 16.88% | 257.56% | 257.56% | 257.56% |
| Total Debt Repaid | -498.79% | 61.54% | -297.99% | -297.99% | -297.99% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 96.63% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 100.00% | -4.87% | -6.91% | -6.91% | -6.91% |
| Other Financing Activities | 10.83% | 6.17% | -13.89% | -13.89% | 3.26% |
| Cash from Financing | 353.37% | 105.16% | 17.21% | 17.21% | 17.21% |
| Foreign Exchange rate Adjustments | -766.57% | -158.62% | 472.73% | 472.73% | 472.73% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 321.04% | -130.31% | 112.64% | 112.64% | 112.64% |